Julie Decock

#cancer Research

[Julie Decock @Julie_Decock]

Check out our latest findings published in Cancers: The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival https://t.co/kdDX8W0BVO #mdpicancers via @Cancers_MDPI

[Julie Decock @Julie_Decock]

Excited to welcome you all to the first @PrecisionExpo #PrecisionGenquest session tonight.
Join me at 5.15pm at Precision Nexus to hear about the exciting work from junior investigators.
#PMES2024, #PrecisionMedicine, #PrecisionHealth

[Julie Decock @Julie_Decock]

Honored and humbled to have been involved in this seminal paper by @JessicaRoelands , @wouterRLH , @MallRaghvendra, Davide Bedognetti and Peter Kuppen.

@QBRI12 , @HBKU , @SidraMedicine , Leiden university medical center

[Nature Medicine @NatureMedicine]

A large, publicly available dataset integrating RNA, whole-exome, T cell receptor and 16S rRNA sequencing from patients with #ColonCancer enables the discovery of a #PrognosticScore consisting of tumor, immune and microbial features. #Microbiome #Tcell https://t.co/wAFGqIs1Mr

[Adviti Naik @advitinaik]

Fantastic opportunity to postdoc in a productive and kind lab with great mentorship! Spent 5 wonderful years working with this collegial team. Do get in touch with @Julie_Decock if you’re interested. https://t.co/IKTcBXgfLi

[Julie Decock @Julie_Decock]

@RobinsonLab_QIB @Rob_T_Johnson Following your footsteps and @edwardslab. I don't care if some might think it is a wrong leadership style, I wholeheartedly took it to heart and apply it in my own group.

[Julie Decock @Julie_Decock]

@Idisbaepigen Thank you for acknowledging our previous work in this area. It is very heartwarming and inspiring to hear how work done during my postdoc many years ago is still relevant and driving further research.

[Julie Decock @Julie_Decock]

Happy to share that our research topic on 'Tumor microenvironment, inflammation, and resistance to immunotherapies' is now completed.
https://t.co/REfTrab12V
@QBRI12, @HBKU

[Julie Decock @Julie_Decock]

Really enjoyed the inspiring talks today at Qatar #STEM education summit. It was my absolute pleasure to engage in thought-provoking discussions as a panellist on the subject "Women in STEM".

@IBEForuM_IBE , @QBRI12 , @HBKU , @QF

#stemeducation , #womeninstem , #genderequity

[Julie Decock @Julie_Decock]

Honored to be part of the panel discussion at the Qatar STEM education summit on March 14th.for more info, check out: https://t.co/JAKTZEbH5U

#stemeducation, #scienceeducation , #womeninstem , #womeninscience

@QBRI12 , @IBEForuM_IBE , @HBKU , @QF

[Adviti Naik @advitinaik]

Really enjoyed putting together this social media campaign for the International Day of Women and Girls in Science, with fellow eLife Community Ambassadors from all over the globe. This day, commemorated on February 11th by United Nations, aims to advoca…https://t.co/cbntEWLYuC

[Julie Decock @Julie_Decock]

happy international day for women and girls in science! Personally, I feel very blessed with all the talented and kind women working with me. Although we have come far, more female role models in STEM are needed. I hope the next generation of young women can accomplish this.

[Julie Decock @Julie_Decock]

@MallRaghvendra Great working with you

[Julie Decock @Julie_Decock]

For the full publication, please go to: https://t.co/6w8iNHSGHM

[Qatar Biomedical Research Institute - QBRI @QBRIOfficial]

Researchers at the Translational Cancer and Immunity Center recently published a new study on the clinical significance of a tumor-based molecular signature that can predict the clinical outcome of patients with 7 different cancer types.

[Julie Decock @Julie_Decock]

Together with Dr Omar Khan and Dr Domenico Mallardo, I am pleased to invite you to submit your original work or review to the @Frontiers topic on '#Cancer genomics in the Era of #precisionmedicine '.

For more info: https://t.co/cbQrm9a61G

@QBRI12 , @HBKU , @CHLS_HBKU , @QF

[Julie Decock @Julie_Decock]

Interested to learn more about the clinical significance of cancer testis antigens as #cancerbiomarkers and #therapeutictargets? You should check out our published research topic @FrontOncology.

https://t.co/7uaLvLXNtk

@FrontiersIn , @QBRI12 , @HBKU , @QF , @CHLS_HBKU

[Julie Decock @Julie_Decock]

Thanks @FrontOncology for highlighting our earlier publication on immunotherapy in TNBC. Still lots of space for improvement in this area. #Immunotherapy
#breastcancer, #TNBC
@QBRI12 @CHLS_HBKU @QF

[Frontiers - Oncology @FrontOncology]

"treatment with immune checkpoint inhibitors has been shown to induce modest responses in metastatic breast cancer"

Read more 👉 https://t.co/TEtLpy9HDL

👨‍⚕️👩‍⚕️ Thomas R, Al-Khadairi G, Decock J

#ICIs #Immunotherapy #TNBC #BreastCancer #BCsm
@Julie_Decock

[Julie Decock @Julie_Decock]

Join us tomorrow for an informative workshop #BreastCancerAwareness

[Qatar Biomedical Research Institute - QBRI @QBRIOfficial]

Have you registered for tomorrow's Breast Cancer Awarenss Seminar yet?
https://t.co/bfFiT0xnAu

@HBKU @QF @QCS_Qatar @HMC_Qatar #BreastCancerAwareness

[Julie Decock @Julie_Decock]

Great initiative!

[Leslie Vosshall PhD @leslievosshall]

We're doing a thing! Speakers @HHMINEWS Science Meetings will no longer put journal names on their talk slides.
Instead display first author, year, PMID (or DOI) like @ardemp
Why?
-end prestige-signaling
-people can actually find reference
#nojournalnamesontalkslides

[Qatar Biomedical Research Institute - QBRI @QBRIOfficial]

Randomized Control Trials (RCT) are often called the golden standard of medical research. What do they mean for Science? To find out more, check out Dr.@Julie_Decock's interview.
@HBKU @QF #cancer #interview #research https://t.co/u32KFXDRnX

[Julie Decock @Julie_Decock]

We identified a 3-lncRNA signature that could be used as minimal informative set of #lncRNAs with #prognostic significance in 7 solid #cancer types.
#PrecisionMedicine

Read more: https://t.co/0WGxtl2wja